<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Conventional cardiac surgical procedures or transcatheter interventions after orthotopic heart transplantation are generally uncommon </plain></SENT>
<SENT sid="1" pm="."><plain>We report the case of a 45-year-old woman who developed severe <z:hpo ids='HP_0001659'>aortic insufficiency</z:hpo> after insertion of a 5-L Impella device 16 weeks after heart transplantation </plain></SENT>
<SENT sid="2" pm="."><plain>After joint evaluation by the transcatheter valve team, transcatheter aortic valve implantation was planned because of associated comorbid conditions </plain></SENT>
<SENT sid="3" pm="."><plain>A 29-mm CoreValve prosthesis (Medtronic, Minneapolis, MN) was inserted percutaneously </plain></SENT>
<SENT sid="4" pm="."><plain>At 6 months after prosthesis implantation, the patient was asymptomatic in New York Heart Association functional class II, and the echocardiogram showed a mean transvalvular gradient of 1 mm Hg, an aortic valve area of 1.5 cm2, and no paravalvular <z:hpo ids='HP_0001659'>aortic insufficiency</z:hpo> </plain></SENT>
</text></document>